KMCSHIL137.80

K M C Speciality Hospitals (India) Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMED
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Returns
Return on Common Equity23.51
Return on Assets18.4314.69
Return on Capital Employed21.16
Return on Invested Capital16.48
Margins
EBITDA Margin27.3226.5326.75
Operating Margin22.5221.6221.54
Incremental Operating Margin15.3720.96
Pretax Margin23.5923.1122.89
Net Income Margin17.4417.1317.15
FCF Margin21.4021.68
Additional
Effective Tax Rate26.0825.8525.10
Sustainable Growth Rate23.51
Incremental Operating Margin %15.3720.96
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.